Grace Larry
Director/Board Member en Generate Biomedicines, Inc. .
Perfil
Grace Larry is currently a Senior Director at Generate Biomedicines, Inc. and a Venture Partner at Alix Ventures.
Prior to his current roles, he worked as an Executive Director at Amgen, Inc. from 2019 to 2021 and as a Director-Asia Operations at Novartis AG from 2011 to 2013.
Mr. Larry has a graduate degree from the University of California, Berkeley, an MBA from Kellogg School of Management, and a graduate degree from Northwestern University School of Law.
Cargos activos de Grace Larry
| Empresas | Cargo | Inicio |
|---|---|---|
Alix Ventures
 Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Director/Board Member | 01/07/2021 |
Antiguos cargos conocidos de Grace Larry.
| Empresas | Cargo | Fin |
|---|---|---|
| AMGEN INC. | Director/Board Member | 01/04/2021 |
| NOVARTIS AG | Corporate Officer/Principal | 01/04/2013 |
Formación de Grace Larry.
| University of California, Berkeley | Graduate Degree |
| Kellogg School of Management | Masters Business Admin |
| Northwestern University School of Law | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
Alix Ventures
Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California. | Finance |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Health Technology |
- Bolsa de valores
- Insiders
- Grace Larry
